FEMLYV
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FEMLYV, covering 2024-07-22 to 2025-07-29. Get the full timeline:
Most recent: FDA Approved: FEMLYV — Supplemental Application (Millicent US, Inc.)
2 regulatory and trial events tracked for FEMLYV, covering 2024-07-22 to 2025-07-29. Get the full timeline:
Most recent: FDA Approved: FEMLYV — Supplemental Application (Millicent US, Inc.)